FDA and DEA call on AD­HD drug man­u­fac­tur­ers to up pro­duc­tion amid on­go­ing short­ages

The US FDA and Drug En­force­ment Ad­min­is­tra­tion sent a joint let­ter Tues­day to the pub­lic say­ing that they’re work­ing over­time try­ing to wran­gle short­ages of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER